Timothy Schmid - 13 Feb 2026 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Feb 2026, 21:11:43 UTC
Prior SEC filing
11 Feb 2026
Next SEC filing
23 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid

Key filing fact

Timothy Schmid filed Form 4 for JOHNSON & JOHNSON (JNJ) on 18 Feb 2026.

Key facts

  • This page summarizes Timothy Schmid's Form 4 filing for JOHNSON & JOHNSON (JNJ).
  • 20 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 18 Feb 2026, 21:11.

Change

  • Previous filing in this sequence was filed on 11 Feb 2026.
  • Current net transaction value: -$3,344,948.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001998491 Primary reporting owner

Schmid Timothy

Relationship
EVP, WW Chair, MedTech
Address
ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK
Signature
/s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid
Signature date
18 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JNJ transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+499
Change %
+2.3%
Price
$0.000000
Shares after
22,624
Date
13 Feb 2026
Ownership
Direct
Footnotes
F1
JNJ transaction

Common Stock

Tax liability

Transaction value
$1,956
Shares
-8
Change %
-0.04%
Price
$244.55
Shares after
22,616
Date
13 Feb 2026
Ownership
Direct
Footnotes
F2
JNJ transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+4,378
Change %
+19%
Price
$0.000000
Shares after
26,994
Date
13 Feb 2026
Ownership
Direct
Footnotes
F3
JNJ transaction

Common Stock

Tax liability

Transaction value
$444,103
Shares
-1,816
Change %
-6.7%
Price
$244.55
Shares after
25,178
Date
13 Feb 2026
Ownership
Direct
Footnotes
F4
JNJ transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,028
Change %
+4.1%
Price
$0.000000
Shares after
26,206
Date
15 Feb 2026
Ownership
Direct
Footnotes
F5
JNJ transaction

Common Stock

Tax liability

Transaction value
$3,652
Shares
-15
Change %
-0.06%
Price
$243.45
Shares after
26,191
Date
15 Feb 2026
Ownership
Direct
Footnotes
F2
JNJ transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,026
Change %
+3.9%
Price
$0.000000
Shares after
27,217
Date
15 Feb 2026
Ownership
Direct
Footnotes
F6
JNJ transaction

Common Stock

Tax liability

Transaction value
$109,066
Shares
-448
Change %
-1.6%
Price
$243.45
Shares after
26,769
Date
15 Feb 2026
Ownership
Direct
Footnotes
F2
JNJ transaction

Common Stock

Options Exercise

Transaction value
$1,576,004
Shares
+13,625
Change %
+51%
Price
$115.67
Shares after
40,394
Date
18 Feb 2026
Ownership
Direct
JNJ transaction

Common Stock

Sale

Transaction value
$3,327,225
Shares
-13,625
Change %
-34%
Price
$244.20
Shares after
26,769
Date
18 Feb 2026
Ownership
Direct
Footnotes
F7
JNJ transaction

Common Stock

Options Exercise

Transaction value
$1,165,331
Shares
+8,998
Change %
+34%
Price
$129.51
Shares after
35,767
Date
18 Feb 2026
Ownership
Direct
JNJ transaction

Common Stock

Sale

Transaction value
$2,200,281
Shares
-8,998
Change %
-25%
Price
$244.53
Shares after
26,769
Date
18 Feb 2026
Ownership
Direct
JNJ holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
745
Date
13 Feb 2026
Ownership
By 401k
Footnotes
F8
JNJ holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
46
Date
13 Feb 2026
Ownership
By ESOP
Footnotes
F9

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JNJ transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-499
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
499
Exercise price
Footnotes
F1
JNJ transaction Derivative

Performance Share Units

Options Exercise

Transaction value
$0
Shares
-4,378
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,378
Exercise price
Footnotes
F3
JNJ transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-1,028
Change %
-50%
Price
$0.000000
Shares after
1,028
Date
15 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,028
Exercise price
Footnotes
F5, F10
JNJ transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-1,026
Change %
-33%
Price
$0.000000
Shares after
2,051
Date
15 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,026
Exercise price
Footnotes
F6, F10
JNJ transaction Derivative

Employee Stock Options (Right to Buy)

Award

Transaction value
$0
Shares
+35,489
Change %
Price
$0.000000
Shares after
35,489
Date
15 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
35,489
Exercise price
$243.45
Footnotes
F11
JNJ transaction Derivative

Restricted Share Units

Award

Transaction value
$0
Shares
+2,548
Change %
Price
$0.000000
Shares after
2,548
Date
15 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,548
Exercise price
Footnotes
F10, F12
JNJ transaction Derivative

Employee Stock Options (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-13,625
Change %
-100%
Price
$0.000000
Shares after
0
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,625
Exercise price
$115.67
Footnotes
F13
JNJ transaction Derivative

Employee Stock Options (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-8,998
Change %
-100%
Price
$0.000000
Shares after
0
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,998
Exercise price
$129.51
Footnotes
F13
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

Footnote F2

Shares withheld for payment of taxes upon vesting of RSUs.

Footnote F3

Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting.

Footnote F4

Shares withheld for payment of taxes upon vesting of PSUs.

Footnote F5

Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

Footnote F6

Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Footnote F7

This transaction was executed in multiple trades at prices ranging from $244.20 to $244.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F8

Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).

Footnote F9

Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).

Footnote F10

Each RSU represents a contingent right to receive one share of Company Common Stock.

Footnote F11

Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Footnote F12

Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Footnote F13

Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .